Stock listing
NASDAQ:KIN Kindred Biosciences Inc Stock
Follow Kindred Biosciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:KIN
$9.25 USD
Close on Aug 30, 2021 · No longer trades
- Lowest – highest close
- $3.15 – $26.50 USDSince Dec 12, 2013 · lowest Jan 25, 2016 · highest Feb 26, 2014
Delisted NASDAQ:KIN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KIN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Kindred Biosciences Inc on 6ix
- Decks
- 9 decks · latest Jun 16, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (June 2021) | Merger or acquisition | 16 slides | Jun 16, 2021 |
| Investor Presentation (January 2020) | Investor deck | 42 slides | Jan 13, 2020 |
| Investor Presentation (September 2018) | Investor deck | 41 slides | Sep 4, 2018 |
| Investor Presentation (May 2018) | Investor deck | 39 slides | May 24, 2018 |
| Investor Presentation (January 2017) | Investor deck | 45 slides | Jan 6, 2017 |
| Investor Presentation (December 2016) | Investor deck | 42 slides | Dec 7, 2016 |
| Investor Presentation (January 2016) | Investor deck | 40 slides | Jan 11, 2016 |
| Investor Presentation (March 2015) | Investor deck | 35 slides | Mar 24, 2015 |
| Investor Presentation (September 2014) | Investor deck | 41 slides | Sep 24, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Oleg Nodelman Other companies: Theravance Biopharma, Inc. (BSFS · Since at least Nov 5, 2026); Aktis Oncology, Inc. (Director · Since at least Jan 8, 2026); Zymeworks Inc. (Director · Since at least Feb 17, 2025); AnaptysBio, Inc. (Member of the Nominating and Corporate Governance Committee · Since at least Apr 8, 2021); Nuvation Bio Inc. (Director · Jun 30, 2020 – Sep 19, 2023 · Past); Panacea Acquisition II Corp (Director · Apr 6, 2020 – Apr 28, 2023 · Past); Prothena Corporation plc (Director · Dec 3, 2019 – Dec 3, 2019 · Past) | Director · Dec 11, 2013 – Sep 29, 2014 · Past |
| Stephen S Galliker Other companies: SELLAS Life Sciences Group, Inc. (Director · Feb 14, 2008 – Oct 10, 2017 · Past); Osteotech Inc (Director · Jun 21, 2006 – Nov 16, 2010 · Past); Dyax Corp (EVP and CFO · May 19, 2006 – Jul 16, 2008 · Past) | Chief Financial Officer · Dec 11, 2013 – Feb 3, 2014 · Past |
| Ernest Mario Other companies: Hyperion DeFi, Inc. (Director · Jan 15, 2021 – Nov 17, 2021 · Past); Soleno Therapeutics, Inc. (Director · Oct 30, 2020 – Jun 6, 2024 · Past) | Director · Jan 20, 2021 – Jan 20, 2021 · Past |
| Richard Chin Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 18, 2025) | Chief Executive Officer, Director · Jan 17, 2020 – Aug 27, 2021 · Past |
| Herbert D Montgomery | Director · Apr 15, 2016 – Aug 27, 2021 · Past |
| Lyndon Lien | Director · Feb 5, 2021 – Aug 27, 2021 · Past |
| Raymond Townsend | Director · Dec 11, 2013 – Aug 27, 2021 · Past |
Log in to ask 6ix AI your own questions about Kindred Biosciences Inc.